Jacobson Pharma Corporation Limited (HKG:2633)
1.090
0.00 (0.00%)
Jul 13, 2026, 10:28 AM HKT
HKG:2633 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,180 | 2,460 | 2,343 | 1,180 | 1,846 | 1,245 | |
Market Cap Growth | -32.93% | 5.00% | 98.55% | -36.07% | 48.24% | -32.29% |
Enterprise Value | 2,696 | 2,952 | 2,503 | 1,616 | 2,969 | 2,550 |
Last Close Price | 1.09 | 1.23 | 1.06 | 0.49 | 0.54 | 0.34 |
PE Ratio | 7.22 | 8.16 | 7.79 | 4.42 | 7.35 | 7.01 |
Forward PE | 6.90 | 7.37 | 7.37 | 7.37 | 7.37 | 7.37 |
PS Ratio | 1.39 | 1.57 | 1.49 | 0.80 | 1.46 | 0.78 |
PB Ratio | 0.93 | 1.05 | 0.95 | 0.49 | 0.57 | 0.42 |
P/TBV Ratio | 1.15 | 1.30 | 1.12 | 0.59 | 1.25 | 1.00 |
P/FCF Ratio | - | - | 8.42 | 3.33 | 3.26 | 3.63 |
P/OCF Ratio | - | - | 4.45 | 2.44 | 2.93 | 3.06 |
PEG Ratio | - | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
EV/Sales Ratio | 1.72 | 1.88 | 1.59 | 1.10 | 2.34 | 1.60 |
EV/EBITDA Ratio | 5.38 | 5.94 | 4.61 | 3.89 | 7.81 | 6.51 |
EV/EBIT Ratio | 6.87 | 7.61 | 5.76 | 5.19 | 11.03 | 10.26 |
EV/FCF Ratio | - | - | 8.99 | 4.55 | 5.24 | 7.43 |
Debt / Equity Ratio | 0.39 | 0.39 | 0.31 | 0.31 | 0.49 | 0.48 |
Debt / EBITDA Ratio | 1.83 | 1.83 | 1.34 | 1.65 | 3.83 | 3.23 |
Debt / FCF Ratio | - | - | 2.78 | 2.11 | 2.82 | 4.11 |
Net Debt / Equity Ratio | 0.21 | 0.21 | 0.09 | 0.12 | 0.16 | 0.30 |
Net Debt / EBITDA Ratio | 0.99 | 0.99 | 0.41 | 0.70 | 1.34 | 2.25 |
Net Debt / FCF Ratio | - | - | 0.81 | 0.82 | 0.90 | 2.57 |
Asset Turnover | 0.44 | 0.44 | 0.44 | 0.33 | 0.25 | 0.33 |
Inventory Turnover | 2.53 | 2.53 | 2.72 | 2.47 | 2.13 | 2.91 |
Quick Ratio | 0.86 | 0.86 | 1.27 | 1.73 | 2.12 | 1.05 |
Current Ratio | 1.37 | 1.37 | 1.88 | 2.59 | 2.68 | 1.43 |
Return on Equity (ROE) | 12.52% | 12.52% | 12.35% | 7.44% | 6.67% | 6.45% |
Return on Assets (ROA) | 6.72% | 6.72% | 7.61% | 4.39% | 3.32% | 3.23% |
Return on Invested Capital (ROIC) | 11.39% | 11.65% | 12.98% | 7.97% | 5.87% | 5.15% |
Return on Capital Employed (ROCE) | 13.60% | 13.60% | 14.10% | 10.00% | 5.70% | 6.30% |
Earnings Yield | 13.83% | 12.26% | 12.84% | 22.62% | 13.60% | 14.27% |
FCF Yield | - | - | 11.88% | 30.07% | 30.72% | 27.55% |
Dividend Yield | 8.26% | 7.32% | 8.46% | 11.19% | 9.68% | 11.54% |
Payout Ratio | - | - | 19.80% | 35.06% | 41.44% | 29.11% |
Buyback Yield / Dilution | -0.59% | -0.59% | -3.42% | -0.45% | 0.21% | 0.03% |
Total Shareholder Return | 7.66% | 6.73% | 5.04% | 10.75% | 9.88% | 11.57% |